Videos

Featured

ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis: Highlights

Michelle Kittleson,

Watch time: 6m 19s

Prakriti Gaba, Joost Daemen, Bernardo Cortese, et al

Watch time: 22m 47s (4 videos)
ACC.23 President Interview With Dr B Hadley Wilson

B Hadley Wilson,

Watch time: 15m 9s
ACC 23: The STELLAR Phase II Trial: Sotatercept in Patients With Pulmonary Arterial Hypertension

Marius Hoeper,

Watch time: 5m 44s
ACC.23 Late-Breaker Discussion: The BIOVASC Trial

Harriette Van Spall, Roberto Diletti,

Watch time: 12m 7s

Mirvat Alasnag, Khaled Al-Shaibi, Erin D Michos, et al

ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
ACC 23 Late-breaker Discussion: The BETTER-CARE HF Trial

Harriette Van Spall, Amrita Mukhopadhyay,

Watch time: 14m 3s
ACC 23: The Evolut Low Risk Trial

John Forrest,

Watch time: 3m 46s
ACC 23: RENOVATE-COMPLEX-PCI: IVUS Vs OCT Optimisation in Complex PCI

Joo-Yong Hahn,

Watch time: 5m 38s

Trending

Atul Pathak, Joost Daemen, Joachim Weil, et al

Mirvat Alasnag, Khaled Al-Shaibi, Erin D Michos, et al

Kausik Ray, , , et al

Watch time: 95m (4 videos)

Bernard Man Yung Cheung, Krzysztof Filipiak, Ganchimeg Ulziisaikhan, et al

Watch time: 1h

Michel Burnier, Roland E Schmieder, , et al

ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC 23: RENOVATE-COMPLEX-PCI: IVUS Vs OCT Optimisation in Complex PCI

Joo-Yong Hahn,

Watch time: 5m 38s

Andrew JS Coats, Stefan Anker,

View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s
ACC 23: BMAD Trial: μCor in Ambulatory Decompensated Heart Failure

John Boehmer,

Watch time: 3m 7s

Events

Filter by

CRT 23: Findings From a Sub-Analysis of the EASTBOURNE Trial

Bernardo Cortese,

Watch time: 5m 21s
CRT 23: The FAST III Randomized Controlled Trial

Joost Daemen,

Watch time: 7m 6s
CRT 23: The OPTIMAL Randomized Controlled Trial

José M de la Torre Hernández,

Watch time: 6m 1s
ACC.23 President Interview With Dr B Hadley Wilson

B Hadley Wilson,

Watch time: 15m 9s
Obesity Management Strategies in 2023

Harold Bays,

Watch time: 17m 7s
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s
ACC 23: The STELLAR Phase II Trial: Sotatercept in Patients With Pulmonary Arterial Hypertension

Marius Hoeper,

Watch time: 5m 44s
ACC 23: BMAD Trial: μCor in Ambulatory Decompensated Heart Failure

John Boehmer,

Watch time: 3m 7s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s

Latest

Filter by

ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis: Highlights

Michelle Kittleson,

Watch time: 6m 19s
CRT 23: Findings From a Sub-Analysis of the EASTBOURNE Trial

Bernardo Cortese,

Watch time: 5m 21s
CRT 23: The FAST III Randomized Controlled Trial

Joost Daemen,

Watch time: 7m 6s
CRT 23: The OPTIMAL Randomized Controlled Trial

José M de la Torre Hernández,

Watch time: 6m 1s

Prakriti Gaba, Joost Daemen, Bernardo Cortese, et al

Watch time: 22m 47s (4 videos)
Industry Spotlight: AGEPHA Pharma

ACC.23 President Interview With Dr B Hadley Wilson

B Hadley Wilson,

Watch time: 15m 9s
Obesity Management Strategies in 2023

Harold Bays,

Watch time: 17m 7s